Artificial Sweeteners: Impact on Metabolism Across Generations

Preclinical research published in Frontiers in Nutrition indicates that popular low-calorie sugar substitutes may negatively affect the balance of microbes in the gut and gene expression in a heritable way. The study, conducted by researchers at the University of Chile, suggests that these effects can persist across generations even when the offspring do not consume the sweeteners themselves.

The research focused on two common non-nutritive sweeteners: sucralose, an artificial sweetener approximately 600 times sweeter than sugar and stevia, a natural alternative extracted from a South American plant. The findings challenge the long-standing assumption that these substances are metabolically inert.

Study Design and Generational Impact

To understand the long-term and heritable effects of these additives, researchers worked with a group of 47 male and female mice. The animals were divided into three distinct groups: one that received plain water, one that received water with sucralose, and one that received water with stevia.

The sweeteners were administered over a period of 16 weeks at levels comparable to those found in a typical human diet. Following this initial period, the mice were bred. The researchers ensured that the two subsequent generations of offspring received only plain water, removing direct exposure to the sweeteners.

The team observed that while there were no differences in glycemic response within the initial group of mice consuming the sweeteners, changes emerged in the following generations. Specifically, the male offspring of the mice fed sucralose exhibited a mildly altered glycemic response in both successive generations.

Microbiome and Gene Expression

The study indicates that zero-calorie sweeteners may subtly reshape the gut microbiome and alter gene activity. These changes are linked to metabolism and inflammation, suggesting that the influence of these additives extends beyond the individual consumer to their descendants through molecular pathways.

Lead researcher Francisca Concha Celume, PhD, from the University of Chile, noted that the observed changes in gene expression and glucose tolerance could be viewed as early biological signals. While the animals in the study did not develop diabetes, the researchers identified subtle shifts in how the body regulates glucose and in the activity of genes associated with metabolic regulation and inflammation.

such changes could increase susceptibility to metabolic disturbances under certain conditions, such as a high-fat diet.

Francisca Concha Celume, PhD

Public Health Context

The University of Chile study was prompted by a broader observation regarding the prevalence of metabolic disorders. Dr. Concha Celume stated that it was intriguing that the prevalence of obesity and insulin resistance has not declined despite the increasing global consumption of sugar substitutes.

While the researchers clarified that sweeteners are not necessarily responsible for these trends, the study raises questions about how these additives influence metabolism in ways that are not yet fully understood.

These findings align with broader concerns from global health organizations. The World Health Organization has suggested that non-nutritive sweeteners may not be effective for weight control and could potentially increase the risk of heart problems and type 2 diabetes. Scientists believe these risks may stem from the way sweeteners alter the body’s handling of energy and sugar.

Limitations and Future Implications

The researchers emphasized that the changes observed were subtle rather than acute. Because the mice did not develop full-scale metabolic diseases like diabetes, the findings are interpreted as markers of increased susceptibility rather than direct causes of disease.

The study underscores the potential for dietary choices to have heritable effects via the gut microbiome and gene expression. Further research is required to determine if these preclinical findings in mice translate to similar metabolic risks in humans across generations.